M
Mike Hernandez
Researcher at University of Texas MD Anderson Cancer Center
Publications - 108
Citations - 4479
Mike Hernandez is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 29, co-authored 99 publications receiving 3476 citations. Previous affiliations of Mike Hernandez include University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.
Daniel R. Gomez,Chad Tang,Jianjun Zhang,George R. Blumenschein,Mike Hernandez,J. Jack Lee,Rong Ye,David A. Palma,Alexander V. Louie,D. Ross Camidge,Robert C. Doebele,Ferdinandos Skoulidis,Laurie E. Gaspar,James W. Welsh,Don L. Gibbons,Jose A. Karam,Brian D. Kavanagh,Anne S. Tsao,Boris Sepesi,Stephen G. Swisher,John V. Heymach +20 more
TL;DR: In patients with oligometastatic NSCLC that did not progress after front-line systemic therapy, LCT prolonged PFS and OS relative to MT/O, and the longer-term overall survival (OS) results accompanied by additional secondary end points are presented.
Journal ArticleDOI
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Daniel R. Gomez,George R. Blumenschein,J. Jack Lee,Mike Hernandez,Rong Ye,D. Ross Camidge,Robert C. Doebele,Ferdinandos Skoulidis,Laurie E. Gaspar,Don L. Gibbons,Jose A. Karam,Brian D. Kavanagh,Chad Tang,Ritsuko Komaki,Alexander V. Louie,David A. Palma,Anne S. Tsao,Boris Sepesi,William N. William,Jianjun Zhang,Qiuling Shi,Xin Shelley Wang,Stephen G. Swisher,John V. Heymach +23 more
TL;DR: Findings imply that aggressive local therapy should be further explored in phase III trials as a standard treatment option in this clinical scenario, and improve PFS relative to maintenance therapy alone.
Journal ArticleDOI
Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience.
Maria E. Cabanillas,Maria E. Cabanillas,Steven G. Waguespack,Yulia Bronstein,Michelle D. Williams,Lei Feng,Mike Hernandez,Adriana Lopez,Steven I. Sherman,Naifa L. Busaidy +9 more
TL;DR: Sorafenib and sunitinib appear to be effective in patients with widely metastatic, progressive DTC, with most patients achieving SD or PR, despite having PD at baseline.
Journal ArticleDOI
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer – A case matched analysis
Pierre Blanchard,Pierre Blanchard,Adam S. Garden,G. Brandon Gunn,David I. Rosenthal,William H. Morrison,Mike Hernandez,Joseph Crutison,Jack Lee,Rong Ye,C. David Fuller,C. David Fuller,Abdallah S.R. Mohamed,Abdallah S.R. Mohamed,Katherine A. Hutcheson,Emma B. Holliday,Nikhil G. Thaker,Erich M. Sturgis,Merrill S. Kies,X. Ronald Zhu,Radhe Mohan,Steven J. Frank +21 more
TL;DR: It is suggested that IMPT is associated with reduced rates of feeding tube dependency and severe weight loss without jeopardizing outcome and Prospective multicenter randomized trials are needed to validate such findings.
Journal ArticleDOI
Contemporary inguinal lymph node dissection: minimizing complications.
TL;DR: The incorporation of novel management strategies and surgical modifications have resulted in decreasing peri-operative morbidity associated with inguinal staging and therapy.